Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease

Table 1

Characteristic of primary antibodies.

Marker	Antibody	Dilution	Positive control	Producer
BCL-2	Mouse monoclonal, clone 124	1 : 150	Colon carcinoma	Dako, USA
MCL-1	Rabbit monoclonal, clone Y37	1 : 50	Tonsil	Abcam, Cambridge, USA
FasL	Rabbit polyclonal	1 : 70	Tonsil	Abcam, Cambridge, USA
Fas	Rabbit polyclonal	1 : 25	Tonsil	Abcam, Cambridge, USA
BID	Rabbit monoclonal, clone Y8	1 : 150	Prostate carcinoma	Abcam, Cambridge, USA
Ki-67	Mouse monoclonal, clone MIB-1	1 : 500	Lymph nodes	Dako, CA, USA
p27Kip1	Mouse monoclonal, clone SX53G8	1 : 50	Tonsil	Dako, USA